Drawing for CAEDO ONCOLOGY

USPTO serial 79335514

CAEDO ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 7117242Status 700Registered
Filing date
Status date
Registration date
Jul 25, 2023
Examiner
LEE, DOUGLAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CAEDO ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Stabe

Susan Stabe Kutak Rock LLP2405 Grand Boulevard, Suite 600Kansas City, MO 64108United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations for treatment of cancer and tumours; Immunotherapeutic preparations; preparations for treatment of cancer; preparations for treatment of tumors; anti-cancer preparations; biological preparations for treatment of tumors; immunostimulatory preparationsACTIVE—
035Retail store services featuring pharmaceuticals, and immunotherapeutic, immunostimulatory and biological products for medical purposes; retail store services featuring pharmaceutical and biological products for treatment of cancer and products for treatment of tumors; retail store services featuring immunotherapeutic products, immunostimulatory products and anti-cancer productsACTIVE—
040Treatment of materials for use in production of pharmaceuticals; custom production and custom manufacturing of pharmaceuticals; custom production and custom manufacturing of immunotherapeutic preparations, preparations for treatment of cancer, preparations for treatment of tumors, anti-cancer preparations, biological preparations for medical purposes, biological preparations for treatment of cancer, biological preparations for treatment of tumors and immunostimulatory preparationsACTIVE—
042Research and development of pharmaceuticals; research and development of pharmaceutical preparations for treatment of cancer, immunotherapeutic preparations, preparations for treatment of tumors, anti-cancer preparations, biological preparations for medical purposes, biological preparations for treatment of cancer, biological preparations for treatment of tumors and immunostimulatory preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 17, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 17, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 17, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 17, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 24, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 24, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 24, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 8, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 12, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 25, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 25, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 25, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 25, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 25, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 10, 2023GPNXNOTIFICATION PROCESSED BY IB—
May 9, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 9, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 19, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 19, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 19, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 15, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 14, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 14, 2022RFRRREFUSAL PROCESSED BY MPU—
Oct 29, 2022ATRVATTORNEY REVIEW COMPLETED—
Oct 28, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 28, 2022CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 4, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 3, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
Jul 23, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 28, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 15, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 11, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance